The report covers:
“I have learned about many atherectomy techniques (rotational, directional, and laser) at academic conferences, but I have never used laser because no sales representative has come to my hospital for introduction of these techniques. I’m very interested in laser ablation atherectomy, and I am not the only one. ”
– Chief Vascular Surgeon, Level 3 Hospital, Beijing, China 2020
Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered. Future trends such as the continued increase in usage of drug-coated balloons and drug-eluting stents are expected to drive the procedure volume growth, laser and rotational atherectomy usage are expected to increase in the future. The increased adoption of newer techniques such as deep vein arterialization, and a decrease in the atherectomy procedural cost are potential game changers to watch out for in the growing PAD interventional devices market.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as the recent NMPA (National Medical Products Association) approval of the Shockwave M5 and S4 Peripheral IVL Catheters by Genesis MedTech Group; Information on ongoing clinical trials by domestic companies such as Zhejiang Zylox Medical Device Co., Ltd. and the ongoing trial for safety and efficacy for BeGraft peripheral stent graft by Bentley Innomed GmbH (in collaboration with Shanghai Micro Medical Devices Co. Ltd) are covered in the report.
What’s in it for you?